Updated: 4/19/2023, 7 a.m. ET
Today, more than half of all abortions in the U.S. involve patients taking a combination of two medications — mifepristone and misoprostol — in order to end a pregnancy at home. This protocol, called medication abortion or colloquially, the abortion pill, has been used by around 5 million women since the FDA first gave its stamp of approval to the practice in 2000.
Now, medication abortion is in jeopardy. A rapidly-moving court battle that began when a U.S. District Judge appointed by former President Trump suspended the FDA’s decades-old approval of mifepristone is headed to the Supreme Court.
Read on to learn more about the unprecedented nature of the case, how abortion clinics are responding, the potential consequences for how drugs are regulated in the U.S., and the possible electoral calculus of another landmark court decision on abortion less than a year Roe v. Wade was overturned.
Image by Anna Moneymaker/Getty Images